4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Mankind Pharma Limited (MANKIND) operates in the Drug Manufacturers - Specialty & Generic industry and is headquartered in New Delhi, India with about 20,451 employees. Its market capitalization is roughly ₹950 billion. In the fiscal year ended 2026-03-31, MANKIND reported ₹142.8B in revenue and ₹19.1B in net income.
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products in India and internationally.
Interactive charts & full statements →
| Income statement | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Total Revenue | ₹142.8B | ₹122.1B | ₹102.6B | ₹87.5B |
| Gross Profit | ₹101.3B | ₹86.4B | ₹70.0B | ₹57.9B |
| Operating Income (EBIT) | ₹28.4B | ₹25.2B | ₹22.4B | ₹16.4B |
| Net Income | ₹19.1B | ₹19.9B | ₹19.1B | ₹12.8B |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | ₹40.3B | ₹34.4B | ₹35.7B | ₹35.7B | ₹30.8B | — |
| Gross Profit | ₹29.3B | ₹24.8B | ₹25.9B | ₹25.2B | ₹22.0B | — |
| Operating Income (EBIT) | ₹8.3B | ₹7.1B | ₹7.0B | ₹6.3B | ₹4.5B | — |
| Net Income | ₹5.7B | ₹5.5B | ₹4.1B | ₹4.4B | ₹4.2B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Dividends Paid | (₹413M) | — | — | — | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets | ₹280.8B | ₹277.6B | ₹119.6B | ₹97.2B | — |
| Total Liabilities | ₹115.2B | ₹131.9B | ₹23.9B | ₹20.9B | — |
INR; ₹M / ₹B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive MANKIND viewer.
This page in other languages: עברית · Русский · Español · Português · 中文 · العربية · Français · Italiano · 日本語 · Deutsch · فارسی · हिन्दी
About TickerBase · Data methodology & sources · Privacy · Terms